Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

1933 Industries Inc C.TGIF

Alternate Symbol(s):  TGIFF

1933 Industries Inc. is a Canada-based cannabis cultivator and producer. The Company is focused on the cultivation and manufacturing of a portfolio of cannabis consumer-packaged goods in a variety of formats for both the wholesale and retail markets. The Company operates through three segments: Alternative Medicine Association LLC (AMA), Infused Mfg LLC (Infused MFG), and Corporate. Its AMA segment is focused on the cultivation and sale of medical and adult use cannabis products. Its Infused MFG segment is focused on the manufacturing of Hemp derived cannabidiol (CBD) products. Its product offerings through its in-house brands, including wholesale flower, pre-rolls, and extracted products under the AMA and Level X brands for the Nevada market; and Canna Hemp, a national CBD brand of wellness products, which include tinctures, gummies, topicals and sports recovery products. The Company owns 91% of AMA, and 100% of Infused MFG LLC Infused.


CSE:TGIF - Post by User

Bullboard Posts
Comment by BaitingBatemanon Aug 31, 2018 10:22am
102 Views
Post# 28548335

RE:RE:MAX STOCK PRICE ?

RE:RE:MAX STOCK PRICE ?First - FNI's latest investor presentation provides the following revenue estimations:
2018 - $15m
2019 - $32m
2020 - $37m
2021 - $48m
2022 - $58m
2023 - $67m

The companies 5-year forecast does not project them hitting $80m - why would you assume that's a possibility in the next year?

Second, assuming they did hit $80m a year, maintained 25% GP and achieved a 1:20 PE valuation -

230m shares issued to date.
270m shares issued upon closing of the current financing (assuming fully subscribed)
310m shares issued if all warrants associated with the current financing are excercised.
40m shares currently reserved for issuance. 

$400m / 270m = $1.48 per share
$400m / 310m - $1.29 per share
$400m / 350m = $1.14 per share

If this company is to hit a $4 per share price, under the 1:20 PE valuation, with 300m shares issued and a GP of 25%, they will need to be achieving $240m a year in revenue with $60m in GP.


Walterthedog wrote: my thoughts are that when they complete the new ama expansion they will have 6 times more product and if they can sell all that, the revenue could be 80m per year or more. if they can cut 20m in profit with a PE ratio of 20:1 , it would make the company fundamentally worth 400m$. of course other growth factors could add value but thats the meat and potatoes im hoping for next year


Bullboard Posts